Get the Stockscreener App
2.03
3.57%
0.07
After Hours:
2.00
-0.03
-1.48%
Elutia Inc stock is traded at $2.03, with a volume of 1,766.
It is up +3.57% in the last 24 hours and up +2.53% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$1.96
Open:
$1.89
24h Volume:
1,766
Relative Volume:
0.06
Market Cap:
$74.71M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.8219
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
+6.84%
1M Performance:
+2.53%
6M Performance:
-36.96%
1Y Performance:
-44.38%
1-Day Range:
$1.89
$2.03
1-Week Range:
$1.82
$2.1599
52-Week Range:
$1.61
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.03 | 80.59M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Will Elutia Inc. continue its uptrendStable Profit Zone and Loss Control Analysis - Newser
Elutia Inc.’s volatility index tracking explainedAI Volatility Forecast and Risk Monitor - Newser
Using Python tools to backtest Elutia Inc. strategiesStock Performance Summary Over One Year - Newser
How many analysts rate Elutia Inc. as a “Buy”Free Stock Ideas For Smart Trading - jammulinksnews.com
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - The Manila Times
Dr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award - The Manila Times
First FDA-Cleared Antibiotic Device for Cardiac Implants Wins Innovation Award | ELUT Stock News - Stock Titan
Will breakout in Elutia Inc. lead to full recoveryFree Short Term Setup With Predictive Chart - Newser
Using R and stats models for Elutia Inc. forecastingOversold Opportunity Scanner with RSI Data - Newser
What makes Elutia Inc. stock price move sharplyForecasting Stock Moves with AI Insights - Newser
Analyzing net buyer seller activity in Elutia Inc.Free Oversold Recovery Opportunity Stocks - Newser
Does Elutia Inc. fit your quant trading modelRisk Shielded Trade Watch with Analysis - Newser
Will Elutia Inc. Benefit From Broader Market BounceTrade Timing Strategy With Technical Data Explained - metal.it
Bollinger Bands Expand on Elutia Inc. — Volatility AheadTrade Timing Strategy With Technical Data Explained - metal.it
Is it the right time to buy Elutia Inc. stockReal Time Signals For Consistent Profits - jammulinksnews.com
What makes Elutia Inc. stock price move sharply Free Community Entry Consensus Trade Ideas - Newser
What makes Elutia Inc. stock price move sharply Free Daily Momentum Screener With Alerts - Newser
Will Elutia Inc. continue its uptrend Free Trend Following Strategy With Stop Loss - Newser
What institutional investors are buying Elutia Inc. stockInvest confidently with proven investment plans - jammulinksnews.com
Why is Elutia Inc. stock attracting strong analyst attentionInvest smarter with daily trading signals - jammulinksnews.com
How does Elutia Inc. compare to its industry peersUncover the best stocks for explosive growth - jammulinksnews.com
Will Elutia Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Selection with 300% Return - Newser
What are the latest earnings results for Elutia Inc.Build a balanced portfolio for long-term success - jammulinksnews.com
How Elutia Inc. stock performs during market volatilityMarket Beating Strategy - Newser
What analysts say about Elutia Inc. stockSuperior profit margins - PrintWeekIndia
Is Elutia Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Elutia Inc. Stock Analysis and ForecastOutperformance with explosive growth - Autocar Professional
What drives Elutia Inc. stock priceHigh-performance investment picks - jammulinksnews.com
KAPA Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Is TENB a good long term investmentHigh-yield investments - jammulinksnews.com
WEAV Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
MSPRW Stock Analysis and ForecastExceptional market positioning - Jammu Links News
What analysts say about FatPipe Inc. stockGame-changing returns - jammulinksnews.com
What drives Middlesex Water Company stock priceSkyrocketing profit margins - jammulinksnews.com
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):